Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 11/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720490 | 0.82 | HRH3 (0.49) | HRH3CYP2D6 | |
| SCHEMBL14720755 | 0.78 | HRH3 (0.40) | HRH3CYP2D6MCHR1 | |
| SCHEMBL14720622 | 0.78 | HDAC1 (0.36) | HDAC1HDAC6HDAC5RXRAGRIN1 | |
| SCHEMBL14721216 | 0.76 | HRH3 (0.40) | HRH3CYP2D6SRD5A2 | |
| SCHEMBL14722974 | 0.75 | HRH3 (0.39) | HRH3CYP2D6MCHR1 | |
| SCHEMBL14720595 | 0.74 | GPR119 (0.48) | CYP2D6 | |
| SCHEMBL14720672 | 0.74 | HRH3 (0.38) | HRH3CYP2D6SRD5A2 | |
| SCHEMBL14721067 | 0.73 | SRD5A2 (0.42) | HRH3CYP2D6SRD5A2 | |
| SCHEMBL14722832 | 0.73 | OGA (0.38) | HRH3CYP2D6SRD5A2 | |
| SCHEMBL14721508 | 0.72 | HRH3 (0.38) | HRH3CYP2D6SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | claimed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |